Literature DB >> 8290026

The participation of cholinergic systems of the nucleus accumbens in the differentiation of acoustic signals in dogs.

K B Shapalova1, E V Pominova.   

Abstract

The influence of microinjections of the choline agonist, (carbacholine 0.05-0.1 microgram), into the nucleus accumbens (Acc) of the right and left hemispheres on the realization of an instrumental defense reflex associated with the maintenance of a specific posture, and on the differentiation of acoustic signals in a defense situation, was studied in chronic experiments in five dogs. It was demonstrated that the injection of fairly small doses of carbacholine (CbCh) into the Acc of the left and right hemispheres improves the differentiation of acoustic signals in the defense situation. The introduction of fairly small doses of CbCh also improves the values of the criteria of the execution of the instrumental defense reaction associated with the maintenance of a specific posture. The changes observed are prolonged in character. Analysis of the motoric components of the instrumental responses made it possible to evaluate objectively the contribution of the motor and sensory mechanisms to those changes which were elicited by the microinjections of CbCh into the Acc, and to reach conclusion regarding an important role of the cholinergic system of the nucleus accumbens in sensory processes associated with the initiation and realization of instrumental responses to defense and differential signals, and especially in the regulation of attention to significant stimuli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8290026     DOI: 10.1007/BF01153674

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  16 in total

1.  [The participation of the neostriatal cholinergic system in the differentiation of acoustic signals in dogs].

Authors:  K B Shapovalova; E V Pominova
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1991 Nov-Dec       Impact factor: 0.437

2.  Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat.

Authors:  K Taghzouti; A Louilot; J P Herman; M Le Moal; H Simon
Journal:  Behav Neural Biol       Date:  1985-11

Review 3.  [Possible neurophysiological and neurochemical mechanisms for participation of the striatum in initiating and regulating involuntary movement].

Authors:  K B Shapovalova
Journal:  Fiziol Zh SSSR Im I M Sechenova       Date:  1985-05

4.  Characteristics of aggressive behavior induced by nucleus accumbens septi lesions in rats.

Authors:  S C Lee; T Yamamoto; S Ueki
Journal:  Behav Neural Biol       Date:  1983-03

5.  Ventral tegmental area lesions differentially affect responses controlled by CS-US contiguity and response-reinforcer contingency in the rat.

Authors:  W J Wilson; E G Baeske
Journal:  Acta Neurobiol Exp (Wars)       Date:  1987       Impact factor: 1.579

6.  GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats.

Authors:  N R Swerdlow; D L Braff; M A Geyer
Journal:  Brain Res       Date:  1990-11-05       Impact factor: 3.252

7.  Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity.

Authors:  D L Jones; G J Mogenson
Journal:  Am J Physiol       Date:  1980-01

8.  Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors.

Authors:  T C Westfall; H Grant; H Perry
Journal:  Gen Pharmacol       Date:  1983

9.  Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens.

Authors:  J De Belleroche; I C Kilpatrick; N J Birdsall; E C Hulme
Journal:  Brain Res       Date:  1982-02-25       Impact factor: 3.252

10.  [Participation of the head of the caudate nucleus of the dog in mechanisms of conditioned reflex postural reorganization].

Authors:  K B Shapovalova; I V Iakunin; M I Boĭko
Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova       Date:  1984 Jul-Aug       Impact factor: 0.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.